source
- NIH funding uncertainty clouds US research, dampens biotech investor sentimentThe latest episode of STAT’s “The Readout LOUD” podcast examined how the National Institutes of Health is allocating its budget and the growing uncertainty surrounding future funding. Hosts Elaine…
- Viatris to acquire Pacira BioSciences for $1.65 billion, expanding its non‑opioid pain portfolioViatris, a maker of generic and branded medicines, announced a cash purchase of commercial‑stage Pacira BioSciences for $1.65 billion. The deal adds Pacira’s non‑opioid pain treatments to Viatris’…